Simplifying Complex Compliance Monitoring Requirements:

Navigating Today's Environment

Live Webinar | Wed, Sep 28, 2022 | 1:00 PM EDT

Speaker

Host

Overview:

Compliance leaders and life sciences always deal with stringent and evolving compliance demands, addressing critical business risks while improving compliance programs to ensure maximum effectiveness.

This webinar explores an informed approach toward building an effective compliance program and touches on other imperative topics, such as the role of data analytics and monitoring in life science compliance.

Discussion Topics:

You will benefit from an interactive discussion about:
Overview of What Makes A Compliance Program Effective and Efficient: From A Life Sciences Company Perspective

What role does compliance monitor play?
What are the expectations of an effective monitoring program
What areas are expected to be monitored and why
How are the areas to monitor prioritized
What role does data analytics play in monitoring, if any?

About Speakers:

Shaun H. Day is a versatile compliance leader with broad international experience in providing commercial and compliance guidance to global companies in the pharmaceutical, medical device, clinical research, energy/electronics, and management services industries.

Through sheer expertise and an optimal level of compliance knowledge and understanding, Shaun has led several compliance teams to success, built relationships in a global environment, and worked collaboratively across all levels of international organizations with unquestionable integrity.

Jim Dawson is dynamic and enthusiastic compliance professional with more than 13 years of comprehensive experience leading billion-dollar companies’ corporate compliance programs in the biopharmaceutical industries. As a skilled communicator with a team-oriented approach, he’s been able to build collaborative relationships across multi-disciplinary business units, executive/senior leadership, and stakeholders at all organizational levels.

Who should attend?

Mid-level to Chief Compliance Officers at drug or medical device manufacturing companies and legal teams working in the life sciences compliance industry.